Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines

S. M. Moghimi, T. L. Andresen

Research output: Contribution to journalLetterpeer-review

23 Scopus citations


The recent unexpected observation that complement activation helps tumour growth and progression has an important bearing on the future development of cancer nanomedicines for site-specific tumour targeting as these entities are capable of triggering complement. These issues are discussed and suggestions are provided for future design and development of safer and effective cancer nanomedicines.

Original languageEnglish (US)
Pages (from-to)1571-1572
Number of pages2
JournalMolecular Immunology
Issue number8-9
StatePublished - May 2009


  • C5a
  • Cancer
  • Complement system
  • Nanoparticles

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology


Dive into the research topics of 'Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines'. Together they form a unique fingerprint.

Cite this